The most commonly reported side effect is temporary nausea, which can often be managed by setting alarms to eat small, frequent meals throughout the day
PCR of wild type allele and targeted allele result in ~1,500bp and ~800bp bands, respectively (left)
Although the muscle loss observed after GLP-1 treatments seem to be in line with the levels of expected weight loss, maintaining or increasing muscle mass can also prevent or retard weight regain in all individuals using these medications
Symptoms include severe abdominal pain, often requiring immediate medical attention
Drug Abuse and Dependence 9.1 Controlled Substance QSYMIA contains phentermine, a Schedule IV controlled substance, and topiramate, which is not a controlled substance